Home » Topics » BioWorld Science

BioWorld Science
RSS

IMpower133 study of Tecentriq in extensive stage SCLC meets coprimary endpoints

June 25, 2018

City of Hope studies memory-enriched T cells in recurrent or refractory glioma

June 25, 2018

Ohara Pharmaceutical obtains certain rights to compound from PRISM Pharma

June 25, 2018

FDA awards orphan drug designation to PCS-499 for necrobiosis lipoidica

June 25, 2018

AZD-9567 shows better therapeutic ratio than prednisolone in vivo and in clinical setting

June 25, 2018

ARQ-531 demonstrates preliminary signs of antitumor activity in B-cell malignancies

June 25, 2018

Phase I results available for CUDC-907 in pediatric solid tumors

June 25, 2018

Lilly's acquisition of ARMO BioSciences complete

June 25, 2018

First-in-human data presented for oncolytic virus Celyvir in solid tumors

June 25, 2018

Biocad initiates phase I study of BCD-132 in patients with multiple sclerosis

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...